Management of Chronic Non-Spinal Back Pain with Normal X-Ray
Start with nonpharmacologic therapy as first-line treatment—specifically exercise, yoga, tai chi, or spinal manipulation—and avoid interventional spine procedures entirely, as they provide no mortality or quality-of-life benefit and carry serious risks. 1
First-Line: Nonpharmacologic Therapy (Mandatory Starting Point)
The American College of Physicians issues a strong recommendation that nonpharmacologic treatment must be the initial approach for chronic back pain lasting more than 12 weeks. 1, 2
Specific evidence-based options include:
Exercise therapy: Provides moderate pain relief (approximately 10 points on a 100-point scale) with best outcomes using individualized, supervised programs incorporating stretching and strengthening. 1, 2
Yoga: Viniyoga or Iyengar styles demonstrate moderate superiority over self-care, with sustained benefits at 26 weeks and decreased medication use. 1, 2
Tai chi: Supported by moderate-quality evidence for chronic back pain management. 1, 2
Spinal manipulation: Has low-quality evidence but remains guideline-recommended. 1, 2
Motor control exercises: Supported by moderate-quality evidence. 1, 2
Acupuncture: Recommended with moderate-quality evidence for chronic pain. 1
Mindfulness-based stress reduction or cognitive-behavioral therapy: Particularly beneficial if psychological factors are present (fear-avoidance behaviors, catastrophizing, depression). 1, 2
Critical principle: Advise staying active and avoiding bed rest, as activity promotes recovery while rest leads to deconditioning and worsens symptoms. 1, 2
Second-Line: Pharmacologic Therapy (Only After Inadequate Response to Above)
If nonpharmacologic therapy fails after a reasonable trial (typically 3-6 months), proceed to medications in this specific order: 1, 2
First medication choice:
- NSAIDs (naproxen or ibuprofen): Most effective pharmacologic option with moderate-quality evidence, providing superior pain relief compared to other oral medications. 1, 2, 3
Second medication choice:
- Duloxetine (30-60 mg daily): Specifically recommended as second-line therapy, particularly beneficial if neuropathic pain component exists. 1, 2
- Tramadol: Alternative second-line option. 1, 2
Last resort only:
- Opioids: Consider only after documented failure of all above treatments, and only when benefits clearly outweigh risks after thorough discussion with the patient about addiction potential and limited long-term efficacy. 1, 2, 3
What NOT to Do (Critical to Avoid Harm)
The 2025 BMJ guideline issues strong recommendations AGAINST the following interventional procedures for chronic axial (non-radicular) spine pain: 1
- Epidural injections of local anesthetic, steroids, or their combination
- Joint radiofrequency ablation with or without joint-targeted injections
- Joint-targeted injections of local anesthetic, steroids, or their combination
- Intramuscular injections of local anesthetic with or without steroids
- Dorsal root ganglion radiofrequency procedures
These procedures do not improve morbidity, mortality, or quality of life and carry risks including deep infection, altered consciousness, paralysis, and death. 1
The 2020 NICE guideline similarly states: do not offer spinal injections for managing low back pain. 1
When to Refer
Multidisciplinary pain management: If pain persists despite optimized nonpharmacologic and pharmacologic therapy over 3-6 months. 2
Immediate specialist consultation: Only for red flags including progressive neurological deficits, cauda equina syndrome, suspected infection, or malignancy. 2, 3
Common Pitfalls to Avoid
Do not routinely order imaging unless red flags are present (progressive neurological deficits, cauda equina symptoms, suspected infection/malignancy, or significant trauma). 2, 3
Do not prescribe acetaminophen as first-line: While historically recommended, it is a weaker analgesic than NSAIDs (less than 10 points difference on 100-point scale) and should be reserved as an alternative when NSAIDs are contraindicated. 1, 3
Do not use muscle relaxants or benzodiazepines for chronic pain: Evidence supports their use only for acute back pain, not chronic. 1, 3
Do not refer for interventional procedures: This represents a major shift from older practices, as the most recent 2025 BMJ guideline strongly recommends against these procedures based on lack of benefit and potential for serious harm. 1